Citadel Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.4M Buy
267,393
+206,746
+341% +$5.72M ﹤0.01% 1583
2025
Q1
$1.35M Sell
60,647
-243,929
-80% -$5.42M ﹤0.01% 2959
2024
Q4
$6.02M Buy
304,576
+106,163
+54% +$2.1M ﹤0.01% 1656
2024
Q3
$4.96M Buy
198,413
+143,593
+262% +$3.59M ﹤0.01% 1773
2024
Q2
$1.02M Sell
54,820
-50,470
-48% -$942K ﹤0.01% 3012
2024
Q1
$2.08M Sell
105,290
-109,406
-51% -$2.16M ﹤0.01% 2454
2023
Q4
$3.77M Buy
214,696
+132,658
+162% +$2.33M ﹤0.01% 1871
2023
Q3
$1.43M Sell
82,038
-119,796
-59% -$2.08M ﹤0.01% 2704
2023
Q2
$2.84M Buy
201,834
+73,022
+57% +$1.03M ﹤0.01% 2147
2023
Q1
$1.39M Sell
128,812
-88,288
-41% -$950K ﹤0.01% 2859
2022
Q4
$3.25M Buy
217,100
+15,872
+8% +$238K ﹤0.01% 2173
2022
Q3
$2.58M Sell
201,228
-159,181
-44% -$2.04M ﹤0.01% 2493
2022
Q2
$3.49M Buy
360,409
+116,759
+48% +$1.13M ﹤0.01% 2217
2022
Q1
$2.42M Buy
243,650
+175,865
+259% +$1.75M ﹤0.01% 2807
2021
Q4
$798K Buy
67,785
+42,150
+164% +$496K ﹤0.01% 4085
2021
Q3
$292K Sell
25,635
-95,849
-79% -$1.09M ﹤0.01% 5042
2021
Q2
$1.69M Sell
121,484
-900,239
-88% -$12.5M ﹤0.01% 3402
2021
Q1
$18.9M Sell
1,021,723
-43,011
-4% -$796K ﹤0.01% 970
2020
Q4
$18.8M Sell
1,064,734
-12,210
-1% -$216K ﹤0.01% 886
2020
Q3
$16.5M Buy
1,076,944
+369,737
+52% +$5.66M ﹤0.01% 838
2020
Q2
$18M Buy
707,207
+185,015
+35% +$4.71M 0.01% 791
2020
Q1
$8.08M Buy
522,192
+155,935
+43% +$2.41M ﹤0.01% 1126
2019
Q4
$4.05M Sell
366,257
-2,333
-0.6% -$25.8K ﹤0.01% 1781
2019
Q3
$3.14M Sell
368,590
-3,697
-1% -$31.5K ﹤0.01% 2006
2019
Q2
$5.04M Buy
372,287
+246,442
+196% +$3.34M ﹤0.01% 1645
2019
Q1
$2.27M Buy
125,845
+89,628
+247% +$1.62M ﹤0.01% 2216
2018
Q4
$1.02M Sell
36,217
-17,376
-32% -$488K ﹤0.01% 2759
2018
Q3
$1.37M Sell
53,593
-36,023
-40% -$919K ﹤0.01% 2481
2018
Q2
$1.56M Buy
+89,616
New +$1.56M ﹤0.01% 2328